News

HARMONY BIOSCIENCES ANNOUNCES FILE ACCEPTANCE OF ITS NEW DRUG APPLICATION FOR PITOLISANT

Know more

Bioprojet will be taking part as sponsor for the 16th European Narcolepsy master class 17th May 2019 and for EUNN congress May 18 & 19

Know more

DATA ON ABUSE POTENTIAL OF PITOLISANT PRESENTED AT 2018 ESRS CONGRESS

Know more

HARMONY BIOSCIENCES PRESENTS 5-YEAR DATA ON PITOLISANT AT INTERNATIONAL NARCOLEPSY SYMPOSIUM

Know more

Bioprojet and Endo Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Pitolisant in Canada

Know more

Bioprojet: Pitolisant Progresses Towards the U.S. Market

Know more

AOP Orphan will distribute Wakix® (pitolisant) from Bioprojet Pharma in Austria, Nordic countries and Central Eastern Europe

Know more

Harmony biosciences acquires us rights to pitolisant from bioprojet; raises $270 million in equity financing

Know more

Jobs

Bioprojet is a company on a human scale, equipped with its fundamental Research Center...

Know more